Patents by Inventor Monica Leung

Monica Leung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-1 Binding Proteins and Methods of Use Thereof
    Publication number: 20230272076
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: August 1, 2022
    Publication date: August 31, 2023
    Inventors: Brydon Bennett, Philip P. Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
    Publication number: 20210069325
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: July 31, 2020
    Publication date: March 11, 2021
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • Methods of treating psoriasis using PD-1 binding antibodies
    Patent number: 10751414
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: August 25, 2020
    Assignee: Celgene Corporation
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20200255525
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 17, 2019
    Publication date: August 13, 2020
    Inventors: Brydon Bennett, Philip P. Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • PD-1 binding proteins and methods of use thereof
    Patent number: 10428145
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: October 1, 2019
    Assignee: Celgene Corporation
    Inventors: Brydon Bennett, Philip Paul Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • METHOD AND MEDICAMENT FOR TREATING AIRWAY AND/OR LUNG DISEASES
    Publication number: 20180319889
    Abstract: The present invention relates to a method and a medicament for airway and/or lung diseases such as moderate and/or severe asthma disease, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and systemic sclerosis. The medicament contains an agent which inhibits TL1A-DR3 interaction, and the method involves administering an effective amount of the agent to a subject to inhibit at least one symptom, feature or condition selected from hyperplasia of epithelial cells, epithelial metaplasia, hypertrophy of smooth muscle cells, and hyperproliferation of smooth muscle cells, production of extracellular matrix, and/or airway and/or lung tissue remodeling.
    Type: Application
    Filed: November 2, 2016
    Publication date: November 8, 2018
    Applicants: La Jolla Institute for Allergy & Immunology, KYOWA HAKKO KIRIN CO., LTD
    Inventors: Michael CROFT, Rana HERRO, David MILLS, Rachel SOLOFF NUGENT, Monica LEUNG
  • METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
    Publication number: 20180092975
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 18, 2017
    Publication date: April 5, 2018
    Inventors: Henry H. CHAN, Eun Mi HUR, Roli KHATTRI, Monica LEUNG, Garth E. RINGHEIM, Peter H. SCHAFER
  • PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20170088618
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 28, 2016
    Publication date: March 30, 2017
    Inventors: Brydon Bennett, Philip Paul Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan